Login / Signup

A European multicentre drug utilisation study of the impact of regulatory measures on prescribing of codeine for pain in children.

Karin HedenmalmKevin BlakeKatherine DoneganMiguel-Angel MaciaMiguel GilJulie WilliamsDolores MonteroGianmario CandoreDaniel MoralesXavier KurzPeter Arlett
Published in: Pharmacoepidemiology and drug safety (2019)
Codeine prescribing for children decreased in line with introduced regulatory measures. Multidatabase studies assessing impact of measures by EU regulators are feasible.
Keyphrases
  • primary care
  • transcription factor
  • young adults
  • chronic pain
  • adverse drug
  • clinical trial
  • pain management
  • neuropathic pain
  • spinal cord injury